Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00616174
Other study ID # H07-01490
Secondary ID H07-01490
Status Completed
Phase N/A
First received February 5, 2008
Last updated March 14, 2014
Start date February 2008
Est. completion date July 2008

Study information

Verified date March 2014
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

The purpose of this study to investigate whether using a special warming blanket during Cesarean delivery helps maintain a normal body temperature in the baby when compared to mothers that are not warmed (standard care at BC Women's Hospital). Doctors observed that some babies have low body temperatures when they are born by Cesarean delivery. Since baby temperatures are dependant on the temperatures of their mothers, we believe that keeping the mother warm during surgery with the use of a special warming blanket that is filled with warm air will result in the baby being warmer at birth.


Description:

Maternal hypothermia during Cesarean delivery is predominately caused by a combination of neuraxial anesthesia and exposure of abdominal contents and skin to the low temperatures of the operating room (OR). Since maternal temperature and fetal temperature are intimately related, neonates experience hypothermia at birth due to maternal hypothermia. Neonatal hypothermia on admission to the Intensive Care Unit is an important determinant of morbidity and mortality, particularly in preterm neonates.

At BC Women's Hospital the majority of Cesarean deliveries are done under neuraxial anesthesia and the pediatricians have observed that some babies had suboptimal body temperatures at the time of Cesarean delivery. The pediatricians wanted to reverse this trend in neonatal hypothermia and requested that the OR temperature be increased to 25oC, more in line with World Health Organization (WHO) guidelines for delivery rooms. However, raising OR temperatures is usually not a comfortable option to the majority of staff working in this environment, therefore WHO recommendations are not followed.

Forced air warming is a common technique used during surgical procedures to maintain normothermia in anesthetized patients. A bi-layered blanket with multiple air channels is connected to a warming device that forces warm air between the layers of the blanket and ultimately around the patient. This device is effective in warming hypothermic patients or maintaining temperature in normothermic patients in a cool OR.

The studies on maternal warming at Cesarean delivery that have been published to date have shown inconsistent findings thus the subject warrants further investigation.

We postulate that actively warming mothers will prevent or decrease the risk of neonatal hypothermia at birth. In addition, we will examine whether active warming has a larger effect in the premature neonate.

Neonatal axillary temperature at delivery will be our primary outcome.

Important variables measured include: neonatal umbilical vein pH, Apgar scores, maternal temperature throughout surgery (uterine incision -delivery time), presence of maternal shivering and maternal thermal comfort score.

This study will be a non-blinded, randomized controlled trial involving two groups:

1. Control group: Standard care i.e. cupboard warmed cotton blanket and cupboard warmed IV fluids.

2. Intervention group: Standard care as in control group plus a Bair Hugger full access underbody blanket model 635 (Health Canada Licence # 12692) warmed by Bair Hugger temperature management unit model 750. Patient will lie on the underbody blanket and it will be turned on once patient is supine on operating table following the insertion of anesthetic. The warming device will be set to the medium temperature setting (380C).

The intervention group will receive a forced air warming blanket throughout surgery.

The study will be conducted in the operating room at the BC Women's Hospital.

The target population is consenting, pregnant women undergoing either elective or urgent (no immediate threat to maternal or neonatal life but requiring delivery) Cesarean delivery under spinal or combined spinal-epidural anesthesia.

Exclusion factors include: emergency Cesarean deliveries or Cesarean deliveries under general anesthesia, mothers in active labor, mothers under 19 years old, those who cannot understand English, and lack of consent. Mothers with a suspected infection, Type I Diabetes Mellitus, a history of malignant hyperthermia and any disease/disorder that is known to affect temperature regulation will also be excluded.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date July 2008
Est. primary completion date July 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years and older
Eligibility Inclusion Criteria:

- All women undergoing elective cesarean delivery under spinal anesthesia or combined spinal epidural anesthesia

- Greater than 28 weeks gestation

- ASA 1 & 2 classification of health

- Mothers presenting to the assessment or labour and delivery unit with ruptured membranes or early signs of labour, but not in active labour, who are not planned for a vaginal birth and who need an urgent cesarean delivery

- Potential subjects need to be able to read and understand English unless independent (non-partner) translator available

Exclusion Criteria:

- Mothers in active labour - 3cm or more dilated with regular coordinated contractions

- ASA 3 or above

- Emergency cesarean delivery for fetal heart rate abnormalities

- Cesarean delivery under general anesthesia

- Maternal age <19 years

- Maternal infection

- Mothers with a CSE where > 5ml of epidural local anesthetic is given prior to the delivery of the fetus

- Mothers with vascular disease - with the exception of hypertension/pre-eclampsia

- Mothers with Type I Diabetes Mellitus

- Untreated hypothyroidism or hyperthyroidism

- Mothers with a history or family history of malignant hyperthermia

- Those who cannot understand English, and lack of consent

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Active warming with Bair Hugger blanket
Standard care at BC Women's Hospital plus a Bair Hugger full access underbody blanket model 635 (Health Canada Licence # 12692) warmed by Bair Hugger temperature management unit model 750. Patient will lie on the underbody blanket and it will be turned on once patient is supine on operating table following the insertion of anesthetic. The warming device will be set to the medium temperature setting (380C). Warming will continue until the end of surgery unless otherwise requested by the mother.

Locations

Country Name City State
Canada BC Women's Hospital Vancouver British Columbia

Sponsors (1)

Lead Sponsor Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal axillary temperature at delivery During delivery Yes
See also
  Status Clinical Trial Phase
Completed NCT03236324 - Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery Phase 2
Recruiting NCT04058444 - The First ERAS Protocol for Cesarean Delivery in Serbia at the University Hospital N/A
Completed NCT03150641 - Delayed Cord Clamping at Term Cesarean N/A
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Completed NCT02846129 - Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery N/A
Completed NCT00799955 - Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block N/A
Completed NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression Phase 4
Completed NCT04358757 - Immune and Physical Recovery Following Cesarean Delivery
Completed NCT01755026 - Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Phase 4
Recruiting NCT03746678 - Patient-Centred Perioperative Mobile Application
Completed NCT03349151 - Postoperative Results of Early Versus On-demand Maternal Feeding After Cesarean Delivery N/A
Completed NCT03729076 - Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia N/A
Completed NCT04799587 - Accupressure of P6 to Reduce Nausea During Cesarean Section N/A
Not yet recruiting NCT05758012 - Carbetocin Compared To Oxytocin During Cesarean Delivery
Completed NCT03781388 - ED90 for Hyperbaric Bupivacaine in Super Obese Parturients Phase 4
Completed NCT04349215 - Validation of the Chinese ObsQoR-11
Completed NCT04812223 - Timing of Umbilical Cord Clamping in Term Cesarean Deliveries N/A
Recruiting NCT05279703 - Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery Phase 4
Completed NCT01550640 - Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia N/A
Completed NCT00884026 - Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia? N/A